This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.
Eligible but out-of-date for cervical cancer screening
Able to speak, read, and communicate well in English or Spanish
Not at greater than average risk for cervical cancer
Pregnant
Incarcerated
Already diagnosed with high-grade precancerous cervical cancer or cervical lesions
Has a compromised immune system